S.C. Sintofarm S.A. (BVB: SINT)
Health Care · Pharmaceuticals · RO
RON—
— today · — 1Y
S.C. Sintofarm S.A. (BVB: SINT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.37M.
trading between 3.50 and 15.00.
Tweenvest scores S.C. Sintofarm S.A. across four factors: quality 71/100, value 38/100, growth 61/100. Its strongest factor is quality.
SINT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.37M
- Revenue (TTM)
- $2.61M
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- RON15.00
- 52-week low
- RON3.50
- Avg volume (3M)
- —
- Shares outstanding
- 3.86M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rapid Dose Therapeutics Corp.CNSX: DOSE | $9.66M | CA$0.10 | -16.67% |
| Concord Drugs LimitedBSE: 538965 | $9.58M | Rs70.40 | -7.00% |
| Active Fine Chemicals LimitedDSE: ACTIVEFINE | $9.55M | Tk4.90 | -10.91% |
| Mercury Laboratories LimitedBSE: 538964 | $9.54M | Rs770.00 | +2.94% |
| Marinomed Biotech AGWBAG: MARI | $9.11M | €— | — |
| InMed Pharmaceuticals Inc.NasdaqCM: INM | $9.04M | $1.36 | +2.26% |
| PEPTONIC medical AB (publ)XSAT: PMED | $8.90M | Skr0.00 | — |
| Amwill Health Care LimitedBSE: 544353 | $8.89M | Rs43.00 | +1.18% |
Figures last refreshed Oct 11, 2026.